• Have a question?
    Open from 8am to 7pm Monday to Friday
    Call customer services
    0345 54 32 600

Candriam Eqs L Biotech R GBP Cap

Price: £556.17|Change: 6.39 (-1.14%)

Management

Name of companyCandriam
Phone+352 27975130
Websitewww.candriam.com
AddressCandriam Luxembourg
SERENITY – Bloc B
Strassen L – 8009
Luxembourg

Fund

DomicileLUX
Legal structureSICAV
UCITSYes
Inception date08/03/2016

Managers

Fund managerLinden Thomson
Manager start date29/02/2024
Biography-
Fund managerServaas Michielssens
Manager start date30/04/2024
BiographyServaas Michielssens has been a Senior Analyst at Candriam since 2016, and became co-manager of the Biotechnology and Oncology strategy since November 2018.He began his career as a PhD student at the University of Leuven Belgium in 2007, where he obtained his PhD in science in 2011. In 2012 he became a postdoctoral scholar at the Max Planck Institute for Biophysical Chemistry in Germany. Servaas holds a master degree in chemistry from the University of Leuven, Belgium and a PhD in science from the same university. Servaas is also a CFA charterholder.

AJ Bell Management Limited (company number 03948391), AJ Bell Securities Limited (company number 02723420) and AJ Bell Asset Management Limited (company number 09742568) are authorised and regulated by the Financial Conduct Authority. All companies are registered in England and Wales at 4 Exchange Quay, Salford Quays, Manchester M5 3EE. See website for full details. AJ Bell procures the provision of the Morningstar Licensed Tools on an “as is” basis and does not guarantee the performance of or accept liability for the Licensed Tools. To the maximum extent permitted by law, AJ Bell excludes liability for the Licensed Tools, including liability for any failure, interruption, delay or defect in the performance of any Licensed Tool, unless it arises as a direct result of the negligence of AJ Bell.

© Copyright 2026 AJ Bell. All rights reserved.